MULTIPLE SCLEROSIS (MS)
Clinical trials for MULTIPLE SCLEROSIS (MS) explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS (MS) trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS (MS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with MS: drug showdown begins!
Disease control OngoingThis study tests two newer drugs, ofatumumab and siponimod, against an older one, fingolimod, in children aged 10 to 17 with multiple sclerosis. The goal is to see which medicine better prevents relapses and has fewer side effects. All participants will take one of the three drug…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
French study tracks daily life changes in MS patients on new drug
Symptom relief OngoingThis study follows 302 adults with multiple sclerosis in France who are starting a new treatment called ofatumumab. Researchers want to see how the drug affects their quality of life over 12 months, including daily activities, mood, and social relationships. Participants fill out…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 20, 2026 11:54 UTC
-
MS drug in pregnancy: new study checks safety for unborn babies
Knowledge-focused OngoingThis study looks at medical records from Finland and Sweden to count how many women with multiple sclerosis (MS) used the drug interferon-beta during the later stages of pregnancy (second and third trimesters). The goal is to see if there are enough cases to study whether the med…
Matched conditions: MULTIPLE SCLEROSIS (MS)
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC